Skip to main content
Premium Trial:

Request an Annual Quote

Science Sales Force

Researchers, writes Prof-like Substance at The Spandrel Shop, have to sell their work. "Like it or not, you're in sales," his blog post title notes. Investigators have to be able to convince their audience — especially a funding agency — that their research idea is good and worth spending the money on.

Prof-like adds that some researchers appear to look a bit down on this skill. "I hear people say, all the time, that so-and-so only got the money because they can sell their work. It is usually said with at least a subtle air of 'my science is better, but they're smoother,'" he writes. "The reality is that selling the ideas is critical to doing the science. Whether you are trying to get money from the federal government, industry or private donation, you still need to get people interested!"

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.